Antioxidant BHT 264
CAS:128-37-0
Purity:99%
Contact Now
We will contact you as soon as possible
Your Location：Home >Products >APi >112811-59-3
Product Details
Reputable manufacturer supply Gatifloxacin 112811-59-3 in stock with high standard We supply high quality 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (CAS 112811-59-3), in stock, factory directly supply to clients, lower prices, more competitiveness.
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid is white powder, while it's Molecular Formula is C19H22FN3O4. An antibacterial.
The CAS number of 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid is 112811-59-3.
More information of 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 112811-59-3 are:
|
Synonyms |
1-Cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylicacid;G-Cebran;Gaity;Gatiflo;Gatilox;Gatiquin;Gatispan;Tequin;Tymer;Zymar; |
|
CAS Number |
112811-59-3 |
|
Molecular Formula |
C19H22FN3O4 |
|
Molecular Weight |
375.4 |
|
Density |
1.386 g/cm3 |
|
Melting Point |
162 °C |
|
Boiling Point |
607.8 °C at 760 mmHg |
|
Flash Point |
321.4 °C |
|
HS CODE |
29335990 |
|
PSA |
83.80000 |
|
LogP |
2.37420 |
|
Pka |
6.43±0.50(Predicted) |
Gatifloxacin belongs to a class of drugs known as quinolone antibiotics and is used to treat acute sinus, lung, or urinary tract infections and sexually transmitted bacterial infection.This drug may be taken orally, in tablet form, or by injection.Common side effects associated with gatifloxacin include nausea, vaginitis(irritation or inflammation of the vagina)，diarrhea, headache, dizziness, and irregular heart beats. In general, gatifloxacin is used in people who are unresponsive to other AOM therapies.In one study, gatifloxacin was compared with amoxicillin/clavulanate in the treatment of recurrent otitis media (OM) and AOM in treatment failures in children.Three hundred fifty-four infants and children with recurrent OM or AOM failure received gatifloxacin or amoxicillin/clavulanate.Results showed that both drugs were well tolerated; the most common side effect was diarrhea.Researchers concluded that treatment with gatifloxacin once daily was as effective as amoxicillin/clavulanate twice daily.In other medical literature, gatifloxacin has been noted as a third-line treatment option in AOM.
InChI:InChI=1/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)
Articles related to 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid:
|
Article |
Source |
|
A high-throughput impurity-free process for gatifloxacin |
Villasante, F. Javier,Gude, Lourdes,Fernandez, Sara P.,Alonso, Olga,Garcia, Elena,Cosme, Antonio , p. 900 - 903 (2008) |
|
STREAMLINED SYNTHESES OF FLUOROQUINOLONES |
- , (2019/01/08) |
Huaihua Yuanyanda Biotechnology Co., Ltd is a quality supplier and manufacturer of 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid . You can buy high quality, low price 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 112811-59-3 here. Contact us.
